Donepezil in the treatment of patients with Alzheimer's disease (Q37464161)

20 August 2017

1 reference

title

Donepezil in the treatment of patients with Alzheimer's disease (English)

1 reference

20 August 2017

0 references

0 references

Norifumi Tsuno

1

1 reference

PubMed ID

19402770

20 August 2017

language of work or name

1 reference

1 May 2009

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

20 August 2017

1 reference

20 August 2017

9

1 reference

20 August 2017

5

1 reference

20 August 2017

591-598

1 reference

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

20 August 2017

1 reference

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

21 January 2018

1 reference

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease

21 January 2018

1 reference

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives

21 January 2018

1 reference

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

21 January 2018

1 reference

An evaluation of the pharmacokinetics of donepezil HCl in patients with moderately to severely impaired renal function

21 January 2018

1 reference

The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin

21 January 2018

1 reference

Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers

21 January 2018

1 reference

Concurrent administration of donepezil HCl and digoxin: assessment of pharmacokinetic changes

21 January 2018

1 reference

Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses

21 January 2018

1 reference

Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses

21 January 2018

1 reference

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

21 January 2018

1 reference

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

21 January 2018

1 reference

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

21 January 2018

1 reference

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

21 January 2018

1 reference

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease

21 January 2018

1 reference

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden

21 January 2018

1 reference

Impact of donepezil treatment for Alzheimer's disease on caregiver time

21 January 2018

1 reference

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

21 January 2018

1 reference

Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial

21 January 2018

1 reference

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

21 January 2018

1 reference

Donepezil preserves cognition and global function in patients with severe Alzheimer disease

21 January 2018

1 reference

Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study.

21 January 2018

1 reference

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease

21 January 2018

1 reference

Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease

21 January 2018

1 reference

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

21 January 2018

1 reference

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

21 January 2018

1 reference

Economic evaluation of donepezil in moderate to severe Alzheimer disease

21 January 2018

1 reference

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 January 2018

1 reference

Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years

21 January 2018

1 reference

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

21 January 2018

1 reference

Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.

21 January 2018

1 reference

Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders

21 January 2018

1 reference

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project

21 January 2018

1 reference

A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression

21 January 2018

1 reference

Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial.

21 January 2018

1 reference

A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule

21 January 2018

1 reference

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.09.23

1 reference

20 August 2017

1 reference

PubMed ID

19402770